Personalized Therapy Selection for the Treatment of Inflammatory Skin Disease: Where Do We Stand?
Time: 2:25 pm
day: Day One Discovery Track PM
Details:
- Review immunologic heterogeneity in common inflammatory skin diseases (atopic dermatitis and psoriasis) and implications for therapy responsiveness
- Outline tools for immunologically phenotyping patients with inflammatory skin diseases and their role in leveraging immunologic heterogeneity in clinical practice and clinical trials
- Discuss the future of personalized medicine in dermatology, biomarker optimization and new opportunities for discovery and drug development
